PLASMA CYSTATIN C LEVEL IS A PROGNOSTIC MARKER OF MORBIDITY AND MORTALITY IN HOSPITALIZED DECOMPENSATED CIRRHOTIC PATIENTS

被引:0
|
作者
Limprukkasem, Tanabute
Pornthisarn, Bubpha
Vilaichone, Ratha-Korn
Chonprasertsuk, Soonthorn
Bhanthumkomol, Patommatat
Kanokwanvimol, Amornnivit
Chotivitayatarakorn, Peranart
Tantiyavarong, Pichaya
Siramolpiwat, Sith
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1518
引用
收藏
页码:S1350 / S1351
页数:2
相关论文
共 50 条
  • [31] Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis
    S. Pouriki
    G. Vrioni
    H. Sambatakou
    A. Alexopoulou
    L. Vasilieva
    I. Mani
    A. Tsakris
    S. P. Dourakis
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 127 - 134
  • [32] Relationship of Plasma Cystatin C level and renal dysfunction in patients with preeclampsia
    Sitepu, Makmur
    Sitepu, Azano
    Marpaung, Johny
    Aldiansyah, Dudy
    Ardiansyah, Edy
    Edianto, Deri
    Sukatendel, Khairani
    BALI MEDICAL JOURNAL, 2019, 8 (02) : 520 - 521
  • [33] Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients
    Diederik G. P. J. Geboers
    Friso M. de Beer
    Anita M. Tuip-de Boer
    Tom van der Poll
    Janneke Horn
    Olaf L. Cremer
    Marc J. M. Bonten
    David S. Y. Ong
    Marcus J. Schultz
    Lieuwe D. J. Bos
    Intensive Care Medicine, 2015, 41 : 1281 - 1290
  • [34] Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients
    Geboers, Diederik G. P. J.
    de Beer, Friso M.
    Tuip-de Boer, Anita M.
    van der Poll, Tom
    Horn, Janneke
    Cremer, Olaf L.
    Bonten, Marc J. M.
    Ong, David S. Y.
    Schultz, Marcus J.
    Bos, Lieuwe D. J.
    INTENSIVE CARE MEDICINE, 2015, 41 (07) : 1281 - 1290
  • [35] Is Cystatin C an Important Prognostic Marker Independent of Renal Function?
    Chen, Horng H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (23) : 1937 - 1938
  • [36] Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis
    Lan, Yan
    Yu, Yue
    Zhang, Xiuding
    Xu, Xianbin
    Yu, Xia
    Tu, Huilan
    Ye, Shaoheng
    Weng, Haoda
    Shi, Yu
    Sheng, Jifang
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [37] Serum Cystatin C is a Powerful Prognostic Indicator in Patients with Cirrhotic Ascites: A Multicenter Prospective Observational Study
    Seo, Yeon Seok
    Park, Soo Young
    Kim, Moon Young
    Kim, Sang Gyune
    Park, Jun Yong
    Yim, Hyung Joon
    Jang, Byoung Kuk
    Park, Seung Ha
    Kim, Ji Hoon
    Suk, Ki Tae
    Kim, Jin Dong
    Kim, Tae Yeob
    Lee, June Sung
    Jeong, Soung Won
    Jang, Jae Young
    An, Hyonggin
    Tak, Won Young
    Baik, Soon Koo
    Hwang, Jaeseok
    Kim, Young Seok
    Sohn, Joo Hyun
    Um, Soon Ho
    HEPATOLOGY, 2014, 60 : 303A - 303A
  • [38] Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients
    Deicher, R
    Ziai, F
    Bieglmayer, C
    Schillinger, M
    Hörl, WH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06): : 1811 - 1818
  • [39] Protein-Calorie Malnutrition As a Prognostic Indicator of Mortality Among Patients Hospitalized with Cirrhotic Portal Hypertension
    Sam, Justina J.
    Nguyen, Geoffrey C.
    GASTROENTEROLOGY, 2009, 136 (05) : A827 - A828
  • [40] Role of Plasma Cystatin C and Urine NGAL in Prediction of Acute Kidney Injury and Mortality in Patients with Acutely Decompensated Cirrhosis: A Prospective Cohort Study
    Park, Sang Hoon
    Lee, Myung Seok
    Yang, Ji Hyun
    Jo, Sang-Kyung
    HEPATOLOGY, 2018, 68 : 563A - 563A